Press Releases

LEVERKUSEN, Germany and BOSTON, Nov. 7, 2019 /PRNewswire/ -- eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of effective human-compatible organs to address the global organ shortage, successfully completed a $100 million Series B financing. The fina

SAN JUAN, Puerto Rico, Nov. 7, 2019 /PRNewswire/ -- Triple-S Management Corporation (NYSE: GTS), a leading managed care company in Puerto Rico, today announced its third quarter 2019 results.

WASHINGTON, Nov. 7, 2019 /PRNewswire/ -- The Leapfrog Group's fall 2019 Hospital Safety Grades, announced today, highlight progress in bringing patient safety into the sun

MEMPHIS, Tenn., Nov. 7, 2019 /PRNewswire/ -- OsteoRemedies®, LLC, a company focused on providing simple solutions to complex disorders, is pleased to annou

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capital market and should be the eleventh 18A Biotech company listed in

SANTA MONICA, Calif., Nov. 7, 2019 /PRNewswire/ -- PatientPop, the leader in healthcare practice growth technology, has received

BUFFALO GROVE, Ill., Nov. 7, 2019 /PRNewswire/ -- Leica Microsystems Inc., a developer and manufacturer of microscopes and scientific instruments for the analysis of microstructures and nanostructures, and Cameron Ehlen Group, d/b/a Precision Lens ("Precision Lens"), have signed an exclusive distribution agreement. Precision Lens, which sells and distributes intraoc

CAMBRIDGE, Mass., Nov. 7, 2019 /PRNewswire/ -- Arkuda Therapeutics, a company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease, today announced the completion of a $44 million Series A financing. Led by a team of drug developers and scientists with deep

CLEVELAND, Nov. 7, 2019 /PRNewswire/ -- GenomOncology, LLC (GO) announced today that it was selected by the Duke Cancer Institute to utilize GO's Precision Oncology Platform to provide real-time therapeutic, prognostic, and clinical trial recommendations to molecular tumor board organizers and participants at Duke Cancer Institute. Duke will l

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactiguard's technology in a global perspective and a new medical applicatio